Preventive maintenance agreement for a stratedigm flow cytometer (base + 4 option periods)

Ended Purchase Order Awarded Last action

Contract number
75F40120P00060
Awardee
Awarding agency
Obligated
$59,027

Award facts

Opportunity
  • 1222559 Solicitation number
Contract value 100% obligated
$59,026.83 Current and potential, with all options
Completion date 100% complete
Current and potential, with all options
Set-aside
No set-aside
Competition
Competed under SAP · 2 offers Simplified Acquisition
Pricing
Firm Fixed Price
Place of performance
Silver Spring, MD 20993, USA

Award details come from SAM.gov/FPDS.

Transactions

Action Obligated Date
Close Out P00005 -$0
Exercise an Option P00004 $14,575
Other Administrative Action P00003 $0
Exercise an Option P00002 $14,575
Exercise an Option P00001 $14,575
Original award $15,303

About this award

The Food and Drug Administration (FDA) awarded a $59,027 firm fixed-price purchase order to Stratedigm, Inc. for preventive maintenance services on a Stratedigm flow cytometer system. The contract, awarded on June 18, 2020, includes a base period and four option periods, with an ultimate completion date of June 17, 2024. The work will be performed at the FDA's Silver Spring, Maryland facility. No set-aside designation was applied to this award, and Stratedigm serves as the prime contractor with no identified subcontractors.

Stratedigm, Inc. is a manufacturer of configurable benchtop flow cytometry systems that provides equipment and maintenance support to the Department of Health and Human Services agencies, including the FDA and Centers for Disease Control and Prevention. This preventive maintenance agreement represents part of the company's broader engagement with HHS, which has awarded Stratedigm over $499,000 in federal contracts since 2019. The maintenance services support the FDA's laboratory operations by ensuring the continued functionality and reliability of the flow cytometry equipment used in research and quality assurance activities.

Quick answers

Who was awarded contract 75F40120P00060?

75F40120P00060 was awarded to Stratedigm, Inc. by Food and Drug Administration (Department of Health and Human Services) on June 18, 2020.

How much is contract 75F40120P00060 worth?

The government has obligated $59,027 on 75F40120P00060.

Was contract 75F40120P00060 competed?

The extent of competition for 75F40120P00060 was competed under sap. The government received 2 offers.

On GovTribe

See this award's full record

  • Every transaction and funding action
  • The awardee's other awards and teaming partners
  • Similar awards and recompete opportunities
  • Ask GovTribe AI about this award